Clinical trial
A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With Alcohol Use Disorder (AUD)
NCT07216872 is registered in ClinicalTrials.gov with Brainsway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With Alcohol Use Disorder (AUD)
- Lead sponsor
- Brainsway
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 7, 2025
- Completion date
- December 1, 2027
- Enrollment
- 186 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol abuse, alcohol abuse/dependence, alcohol addiction, alcohol dependence, alcohol use disorder, alcoholism